Tevogen Inc. - 10-Q Filing

Tevogen Inc. reports Q3 2026 financial results featuring significant equity structures including Series A, B, and C preferred stock and unsecured debt via The Patel Family LLP.

SEC EDGAR ·

Tickers: $TVGN

Read the full article at SEC EDGAR

More Regulatory news